28 Burst results for "Blood Disorder"

EMA discusses Johnson and Johnson possible link to blood clots

AP News Radio

00:38 sec | 3 months ago

EMA discusses Johnson and Johnson possible link to blood clots

"Experts at the agency that regulates drugs for the European union says a warning about very unusual blood clots should be added to labels for Johnson and Johnson's coded nineteen vaccine the European medicines agency says these rare blood disorders should be considered as very rare side effects of the vaccine European officials say they consider the old current available evidence from the U. S. including eight reports of serious cases over red blood clots associated with low blood counts including one death I'm Charles de Ledesma

Johnson European Medicines Agency European Union U. Charles De Ledesma
EU Agency Calls For Blood-Clot Warning on J and J Vaccine

WTOP 24 Hour News

00:33 sec | 3 months ago

EU Agency Calls For Blood-Clot Warning on J and J Vaccine

"The Johnson and Johnson covert vaccine should come with a warning about blood clots. Last week, J and J stopped its European rollout after US officials recommended a pause in the vaccine when they detected six very rare blood clot cases. Among nearly seven million people who had been vaccinated. The European Medicines Agency says the rare blood disorder should be considered as a very rare side effect. The U. S could be getting use of the vaccine again later this week. It's not clear yet when it will be distributed again in Europe. Traveling outside the U. S. The spring or

Johnson European Medicines Agency United States Europe U.
Covid vaccine: PM to have AstraZeneca jab as he urges public to do the same

FT Politics

08:50 min | 4 months ago

Covid vaccine: PM to have AstraZeneca jab as he urges public to do the same

"When johnson talks about the uk's world-beating response to covid nineteen vaccine pogrom passes muster. It's been an unqualified success or one of the reasons. His conservative party are so far ahead in the polls over twenty five million brits have received their job so fall but the government unexpectedly announced show fall in the number of vaccines delivered in april juice. Supply issues and the debate has a geopolitical angle. To given the you struggling with its own vaccine rollout slovan the line. The european commission president on the block might even consider export controls. All options are on the table. We are in the crisis of the century. And i'm not ruling out any anything for now because we have to make sure that europeans are vaccinated as soon as possible so sarah. Let's begin with the overall state of the uk's vaccine pogrom based on what was set out in december. It's pretty much all going to plan fairly high levels of takeover ninety four percent i believe and the government is insisting that all over fifty will have had their first job by the middle of april. So what's the problem. Well a week ago we would have said. This was indeed the most Astonishingly amyloid success and a sign of vessel. Buoyant moved around it. Was that the with some very clear briefing to a couple of the saturday newspapers suggesting that we were actually going to move to the over forty's much sooner than expected so it was a bit of a jolt to find out on wednesday that in fact. Nhs people involved in the program had been told that they must hold booking any new appointments throughout april because the been a sudden very significant reduction in the supplies available so that really has put the first serious dent in the narrative which right from december the eight. I think it was the day. That william shakespeare became one of the first two vaccine as now suddenly. The government is in the unaccustomed position of having to explain what's happening and explain why some of the public expectations that they'd raised so hard may not be met to be fair to the government. They still absolutely insisting they're on track with the two big dates that they've set for this program that all over fifty should be vaccinated by the middle of april. And all adult britons. Who wants a job will have had it at the end of july. But there's no question that it's been a difficult political management problem for them this week and very much not the position that they'd hoped to be in the club. Let's have a look at why this might be happening and seven. I spent a lot of this week speaking to people. Whitehall trying to figure out exactly what was going on behind the scenes with matt. Hancock gave us a of clarity in the house of commons and the government is pinning own production issues. The first one is this batch of one point seven million jobs that we sent back for testing and the second thing is the supply from the soham institute of india which again the governor's put down to supply issues but others are saying that actions being blocked by modi's government from shipping out to the uk. Exactly it is pretty opaque what's happening. There are two elements. Here that can hold up. Supplies one is the genuinely technical difficulties in producing a complex biological process. I mean it's not straightforward zanu vaccine and a lot of the manufacturing sites haven't made this sort of marin a vaccine before it scale factor. You could say none of them have because this is the first one. That's the fiso won. The astra zeneca at novartis vaccine is also level to a complicated process. So there are technical supply issues and then there at the political ones. You alluded to and i don't know whether the serum institute of india supply has been blocked for political reasons because india was having rather a good downturn in covert cases. But that's turning up again. Unfortunately and there are feelings. That indian government wanted to have it at home. This is so. I think if we look at the context of this a lot of it is actually not that much of a serious problem that we were crunching the numbers this week and april is a significant moment in the vaccine program for the uk. Because yes they were vaccinated all over fifty which according to people like christie chief medical officer of england which uses ninety nine percents of deaths on messages the pressure on the nhc s. But eneko you have to install the second jobs. Really the po- gum began to scale up towards the end of january and eleven week window. The nhl is set between the first and second doses. That really kicks in april and but hancock said this week that really still going to be delivering about fourteen million jobs throughout april which is low though. It's been in march but it's still a pretty high number so it's probably good to keep it in context with feels really what's gone wrong. Here is expectations that the rogue briefing about forty s really feels like delivers come off the bush tourism bush. Johnson's tried to restrain for much of twenty twenty. One yes and i think some. Nhs officials were less than delighted about that huge raising expectations last weekend. In a way. I think this was always going to be a difficult point for the program. It was absolutely predictable that at the point at which second doses to scale up there was going to be a deep in first doses. So it's perhaps unfortunate that there wasn't more subtle public preparation. You're absolutely right international standards even in april. We're still going to be doing more. Vaccinations than many of our counterparts. So it's particularly unfortunate wasn't better preparation. Because i think in the minds of a lot of britain's the will now be a sense of this program isn't doing well it's stumbled. It didn't have to be this way that it could have been very differently presented. And after all as i said the government is still on track to meet those two deadlines that it says now clive. We need to put this in the context of europe as well and we heard from s. the von d'alene at the top. That and you still really struggling with its vaccine vo loud but the most baffling things. She's seen this week. Is the story about the astra zeneca job and how effective or side effects. That may have in this concern. Over blood clots we heard from the ama from the nhra in the uk from the world health organization. All saying there are no concerns about blood. Clots and ashes annika vaccine yet at didn't stop lawson countries from halting giving out the doses. It's a very complicated picture on side effects. At least the spotlight turned away from efficacy. Before countries in continental europe were worrying that the astrazeneca vaccine wouldn't work well enough to older people. I think the efficacy questions have more or less be answered now. The spotlight is on whether they're adverse side effects and a few of those have been discovered there. These two different sorts of blood disorders do with abnormal clotting thrombosis that have been detected in people who just been vaccinated in norway in germany elsewhere on continental europe. The numbers are tiny. I would say fewer than twenty around the continent. Investigation is still continuing. There's no proven link with the vaccine. But a lot of vaccine knowledge ists the might be a link. But that is no reason to stop the vaccination program when it's saving tens of thousands of lives probably and people have said that just by halting for a few days the astrazeneca vaccination and continental europe. This week until the european medicines agency said it was okay that would have cost lives. It loves cost lives directly because people weren't getting vaccinated and it also probably unfortunately of cost lives indirectly because all the publicity about ad side effects will just undermined confidence in the vaccine

UK Government Soham Institute Of India Astra Zeneca Serum Institute Of India Eneko European Commission William Shakespeare Whitehall Johnson Modi House Of Commons Sarah Hancock Novartis NHC Bush Matt
Gene-editing treatment shows promise for sickle cell disease

Morning News with Hal Jay & Brian Estridge

03:09 min | 8 months ago

Gene-editing treatment shows promise for sickle cell disease

"Preliminary data out there that they're calling nothing short of great. It's new data on crisper treatments for blood diseases, Okay? This crisper C l c R i s p R is gene editing therapy? Okay, and this is specifically dealing with blood disorders. That are inherited things like sickle cell. Okay, okay, And these folks who have been treated with this gene editing therapy have shown consistent and sustained response with manageable side effects. The these two crisper therapeutics is the name of the company. They in a Vertex Pharmaceuticals are jointly developing a one time gene editing treatment. They call it C t x 001. And I know they were kind of getting in the weeds here. But here's the deal after giving the therapy by infusion, all the patients in both studies. Have been free from symptoms of the disease is and have not needed blood transfusions. Wow, that's amazing, all of them all of them in free of the symptoms Now, do they have an in home model that you could take up with? It's not there yet course But this This is huge, though. Um, they're also going to be some clinical trial results on the sickle cell gene therapy from another group called Bluebird Bio. S So you got a couple of gene therapies that are taking a look at this sickle cell anemia. You also have beta thalassemia is another one. I'm sure I'm saying that wrong Well, last Mia, but it says Hey, We've made a real pivot and what we've been waiting for. And now we're finding the ability to offer patients long term disease control using genetics and genetic therapy. I've heard some reports on this and one of the woman women that got the therapy. Said It was night and day. The chicken function. I mean, she and I didn't realize how painful Oh, yeah. Sickle cell is and yeah, she said she has a life again. Yeah, it was like Almost immediate Like when they got the confusion. That is awesome. Yeah. Inwood sickle cell with the sickle red cells become clogged and blood vessels and then you get extreme pain that can also lead to like organ damage, stroke, early death things like that. Uh, And so, I mean, this could be huge. How That if they can figure out a way to just edit the gene that's causing sickle cell and they do it with a one time infusion and then your transfusion free. So this this this This could game changer for all different kinds of cheeses. How about this out? The average sickle cell patient right now has to have 15 blood transfusions a year. You gotta be kidding. No, I had no idea and this would eliminate that. That is so bad for the one time infusion.

Vertex Pharmaceuticals Bluebird Bio Thalassemia Inwood Sickle Anemia Sickle Confusion Stroke
Phyllis George, female sportscasting pioneer, dies at 70

Jason and Alexis

00:25 sec | 1 year ago

Phyllis George, female sportscasting pioneer, dies at 70

"George nineteen seventy one to miss America who would later become a pioneer in female broadcasting by co hosting CBS's the NFL today in nineteen seventy five passed away Thursday at seventy after a battle with a blood disorder the NFL today co host Brent Musburger tweeted Phyllis didn't receive nearly enough credit for opening the sports broadcasting door for dozens of talented women who took her lead and

George America CBS NFL Blood Disorder Brent Musburger Phyllis
Seattle filmmaker Lynn Shelton dies at 54

Own It

00:24 sec | 1 year ago

Seattle filmmaker Lynn Shelton dies at 54

"Filmmaker Lynn Shelton grew up in Seattle graduated from the university of Washington her publicist says she has passed away looks like cause of death was a blood disorder according to The Seattle Times Shelton was the first local filmmaker to have her work open the Seattle international Film Festival that was in twenty twelve her latest film sort of trust open since last year when Shelton was fifty four years old

Lynn Shelton Seattle Blood Disorder University Of Washington
The Big Dilemma Facing the U.S. Healthcare System

Medicine, We're Still Practicing

06:57 min | 1 year ago

The Big Dilemma Facing the U.S. Healthcare System

"Are we supposed to juggle the cost of medicine? insurance company limitations and hospital economics. If we'RE GONNA try to enhance patient outcomes that is the big dilemma is that we have tremendous standards in terms of healthcare in our expectations that we were going to provide the the best and the greatest and the newest healthcare available to who are patients. And yet we have this notion that this is GonNa come from vaporware that somehow it will be provided to us and and yet we're really at a crossroads a realizing that our Medicare system is straining relative to the dollars that are available Research Searching Development is taking place in the private sector but then the rest of the consumers are feeling the pain because they're having to pay extreme costs in as as far as their medications are concerned and the entire system sort of feels as if it's a row about ready to collapse how can maintain high quality cutting edge medicine and still manage the economics and those two things are so diametrically opposed and so much of our gross national the product is already being spent relative to healthcare and yet we're drowning Medicare's rationing insurance companies are rationing they're hiding the rationing that's going non but there's rationing going on nevertheless so can i. Can I ask this Howard. Does Kaiser have a unique view of how to manage this problem. I think Especially from the point of view Kaiser Permanente we feel that there are some relatively more simple approaches to health care where it's not all just about spending money on the latest when greatest technology or pharmaceutical For example Prevention we in the United States are much more engineered To have patients get great treatment when they're sick but not really engineered to make sure that they get all the preventive care that they should get and there are literally and insurance wise and everyone who say engineered and every one of those ways we first of all. We don't talk about enough. We don't talk about prevention now. We don't advocate enough for it. And we don't have financial incentives centers that favorite prevention or financial. Incentives favor taking care of people. When they get sick we spend a lot more money per unit time for doctorates CETERA? When someone on a sec then giving them advice on how to prevent them from any sick so if we just could get every single American to do the tests and take the treatments from preventive standpoint that we know work that right there would improve health and that right there would reduce costs and that was certainly something we accuse a permanent? They felt very strongly about and had trump have tremendous data. Show that we've been doing. Those things are very very substantial way making sure that populations of patients get their mammograms. Hypertension screens take basic medications occasions. That work for their condition. But you have to make sure that large numbers of patients in the population do it because of all small population percent do it. You won't get the same benefits so one of many countries around the world and in fact we're starting to do it better in this country. No country does a perfectly however In in fact still that's a problem that that's a problem that is actually international nature but Some countries that are doing better at it include Germany the United Kingdom even the National Health Service where people have their criticisms at times about service and whatnot in the NHL NHL does give care. That's very evidence based But no one country has got a monopoly to give great prevention. That's just a huge opportunity for us and everybody else as well let me give you a negative example from this country. We wish I'm noticing Historically we do screening blood tests on patients every year Complete blood count a comprehensive metabolic panel looking looking at kidney function liver function Your Lipid profile your cholesterol your LDL your HDL etcetera etcetera. And historically this has been paid aid for by insurance companies has been paid for by Medicare currently Medicare and then subsequently other insurance companies have followed that we we will do a blood count if you have a blood disorder. So if you're anemic we will justify doing a blood count if he had kidney failure. We'll just we are justified in running your creatine in your kidney function test if you have thyroid disorder than we will pay for that. But if you don't have that you don't have any of these disorders. We no longer pay for routine screening laboratory data. So does that mean that. The insurance companies have not adopted the principle that preventive care actually ends up costing them less than long run to not pay for the screening blood tests will save millions for private insurance companies as well as for Medicare. So how. You're you're you're focused on how we create better outcomes for patients. Isn't this part of the problem. And what do you suggest do we do about it. Yeah so I can at Kaiser Permanente we didn't control doctors ordering habits. A doctor can do anything That they think is appropriate for a patient and we didn't and tell them not to order tests and whatnot but in particular. We strongly encourage them to do things that are evidence based so. If there's a test to be done that would help detect something early. We actually want doctors to do do that. And and have a very good record of accomplishing that. I mean again. We didn't restrict people from practicing the way they felt was best based upon their view of the clinical evidence in the in the patient's patient's condition however it's similar to what happens in government when governmental When when they're tough times and government budgets challenge they tended slash ask things they took the cup? Because that's the only way they can balance the budget so as we get closer to Medicare insolvency and insurance companies are having problems with costs. They they start getting into to cost savings mode and those those cost-saving modes and not necessarily evidence base. So that you stuck maybe cutting out the baby with the bathwater a little bit and don't intelligently try to to figure out what you should do and what. You should not do. What I'm advocating for is to try to use scientific evidence as much as possible to make thorough assessments of these various technologies analogies are tests and then use the evidence that comes forward and make sure people do get these tests are do get these therapies as opposed to basically you want to use this you want to use this information to convince the healthcare economic controllers the insurance companies to think differently about the pro? I do but I also understand. It's it's it's easy to just blame the insurance companies and I'm not here to be an apologist and then you way for Insurance companies or explain what they do again. I'm very proud of what we did in Kaiser Permanente because because we were not just an insurance company also provider of care and we have a really good record of policy but I do think that the opportunities for improving health certainly exists at the insurance level. The exists at the physician level but they also existed the patient

Kaiser Permanente Medicare Kaiser Research Searching Development United States Howard Blood Disorder NHL Hypertension Thyroid Disorder Germany National Health Service United Kingdom
CRISPR For Sickle Cell Disease Shows Promise In Early Test

Michael Medved

00:26 sec | 1 year ago

CRISPR For Sickle Cell Disease Shows Promise In Early Test

"Sickle cell disease is an inherited blood disorder affecting about a hundred thousand Americans mostly African American it's a debilitating condition causing in the media delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I

Blood Disorder
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
"blood disorder" Discussed on AP News

AP News

12:47 min | 1 year ago

"blood disorder" Discussed on AP News

"The food and drug administration's approved a doc fee for patients 16 and older it's given as a monthly infusion and cuts in half the occurrences of sickle cell pain episodes but the drug from Novartis AG is pricey between 85000 and $113000 a year sickle cell disease is an inherited blood disorder affecting about 100000 Americans mostly African American it's a debilitating condition causing anemia delayed growth vision problems and painful swelling and hands and feet because the organ damage from sickle cell disease shortens the lives of patients there is ongoing testing to see if a deck video might address that too I Jackie Quinn

Novartis AG blood disorder Americans Jackie Quinn $113000
White couple give birth to Asian daughter after alleged sperm mix-up

Joel Riley

00:41 sec | 2 years ago

White couple give birth to Asian daughter after alleged sperm mix-up

"New Jersey fertility clinic today being ordered to hand over sperm donor list after a white couple gave birth to an Asian baby couple claims the institute for reproductive medicine and science impregnated the wife with the sperm of someone who was definitely not the husband they say DNA tests confirm their daughter is not biologically related to her dad that she also has a blood disorder they say could not have been contracted from them it's it's one of those things that you know not so long ago you never hear the story because this kind of thing didn't happen and now if you don't have all the tease crossed and I's dotted and you've got a baby. that technically biologically is not yours it's

New Jersey Fertility Clinic Blood Disorder
A Brief History of Sickle Cell Disease

The Pulse

02:09 min | 2 years ago

A Brief History of Sickle Cell Disease

"Story is about a disease that could have been mostly wiped out. But it wasn't. It's a story about a public health campaign gone wrong, sickle cell disease is an inherited blood disorder blood cells bend into a sickle shape, which causes blockages and starves tissue of oxygen this illness affects people of African descent as well as Mediterranean and south Indian peoples. The American government took aim at sickle cell in the nineteen. Seventies jets Lehman reports on how public health missed the Mark. It's March nineteen seventy-two. Bobby Seale speaking in a crowded gym. And we're not saying that. Vava programs are necessarily revolutionary. He's the co founder of the Black Panther party, a radical African American civil rights organization founded in California survivor programs to and institutions by which we unify people around Abana reads sickle cell, anemia testing black community survival conference a blood test shows if you have the sickle cell trait or not. Trait carriers usually don't have any symptoms. But if two people who have the trait have children their kids may develop sickle cell disease, which can be fatal the Black Panthers had been calling attention to sickle cell for years. And it looked like the government had finally started to listen congress had approved a fivefold increase in sickle cell research. Funding, president Nixon made fighting the disease a priority. America has long been the wealthiest nation in the world. Now, it is time we became the healthiest nation in the work sickle cell testing had been possible for decades. Now there was funding as wills a mandate from the leader of the free world. We were going to stop sickle cell in America once and for all. Only we didn't. This is a young girl in her bed. Tears streaming. She's in sickle cell crisis.

Sickle Cell Trait Black Panther Party Bobby Seale American Government America Blood Disorder President Nixon Mediterranean Lehman Congress Abana California
Development of gene therapy for blood disorders

WBZ Morning News

00:22 sec | 3 years ago

Development of gene therapy for blood disorders

"A, Cambridge based biotech in a Boston based pharmaceutical company are working together to study a gene editing drug in humans crisper and vertex began the study this week in Germany treatment targets a rare blood disorder that reduces the amount, of, oxygen-carrying red, blood cells in. The human body study is expected to run through may of, twenty twenty

Red Sox Kevin Youkilis Boston California Michael Monsour United States Blood Disorder New England Navy Germany Jeff Brown Cambridge Scott